EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interferon-α for Immune Modulation in Chronic Hepatitis B Toward Functional Cure

Asha Ashuo, Jia Liu, Zhenghong Yuan, Jieliang Chen iD

Viruses · 10.10.2025 · 17 (10) · 1358

DOI: 10.3390/v17101358 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 10.10.2025. Verfasst von Asha Ashuo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecular Virology (MOE/NHC), Research Unit of Cure of Chronic Hepatitis B Virus Infection (CAMS), Shanghai Frontiers Scien…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Interferon-alpha, Hepatitis B virus, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key R&D Program of China, the National Natural Science Foundation of China, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis B (CHB) remains a major global health challenge, largely due to the persistence of covalently closed circular DNA (cccDNA) and impaired host immunity. Interferon-α (IFN-α), a key antiviral cytokine, not only directly restricts HBV replication but also orchestrates innate and adaptive immune responses. This review summarizes current advances in IFN-α-mediated immune regulation, highlighting its effects across diverse immune cell populations. Evidence indicates that IFN-α can reprogram immune responses to promote viral clearance, although clinical efficacy is limited by modest response rates and adverse effects. Recent progress in cytokine engineering, subtype research, and rational combination strategies—including nucleo(s/t)ide analogs, RNA interference therapeutics, antisense oligonucleotides, therapeutic vaccines, and beyond—has expanded opportunities to improve treatment outcomes. While challenges remain, these advances lay the foundation for optimizing IFN-α–based interventions and highlight IFN-α as a key driver for innovative therapies aimed at achieving a functional cure of chronic hepatitis B.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicInterferon-alphaHepatitis B virusAntiviral AgentsImmunomodulationHumansImmunity, InnateAnimalsVirus ReplicationAdaptive Immunity

Stichwörter der Autor:innen

HBV curePEG-IFNαchronic hepatitis Bcombination therapyimmune modulation

Substanzen

Interferon-alphaAntiviral Agents

Autor:innen und Institutionen

  • Key Laboratory of Medical Molecular Virology (MOE/NHC), Research Unit of Cure of Chronic Hepatitis B Virus Infection (CAMS), Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, School of Basic Medica…
  • Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China.

ORCID-Profile: Jieliang Chen

Förderung

  • the National Key R&D Program of China
  • the National Natural Science Foundation of China
  • National Key R&D Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Ashuo, A., Liu, J., Yuan, Z., & Chen, J. (2025). Interferon-α for Immune Modulation in Chronic Hepatitis B Toward Functional Cure. Viruses, 17(10), 1358. https://doi.org/10.3390/v17101358

Vancouver

Ashuo A, Liu J, Yuan Z, Chen J. Interferon-α for Immune Modulation in Chronic Hepatitis B Toward Functional Cure. Viruses. 2025;17(10):1358. doi:10.3390/v17101358

BibTeX
@article{Ashuo2025,
  author = {Ashuo, Asha and Liu, Jia and Yuan, Zhenghong and Chen, Jieliang},
  title = {Interferon-α for Immune Modulation in Chronic Hepatitis B Toward Functional Cure},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {10},
  pages = {1358},
  doi = {10.3390/v17101358}
}
Kostenlos starten →